Eric Miller, PhD
Founder / CEO
Dr. Miller earned his PhD in Chemical Engineering from MIT in 2019 and has over a decade of experience in developing minimalist antibody mimetics. He specializes in agile protein engineering, applying efficient design principles and rapid iteration to accelerate therapeutic discovery. His work focuses on higher-order functional selection strategies, enabling the precise development of next-generation biologics.